{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:28:16Z","timestamp":1791271696844,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.yrtph.2004.09.001","type":"journal-article","created":{"date-parts":[[2004,12,13]],"date-time":"2004-12-13T22:57:31Z","timestamp":1102978651000},"page":"28-38","source":"Crossref","is-referenced-by-count":7,"title":["A thirteen week dietary toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats"],"prefix":"10.1016","volume":"41","author":[{"given":"B.","family":"Lina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Korte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Unkila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2004.09.001_bib1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0022-4731(87)90200-7","article-title":"Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG)","volume":"27","author":"Adlercreutz","year":"1987","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1470-2045(02)00777-5","article-title":"Phytoestrogens and cancer","volume":"3","author":"Adlercreutz","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/298659a0","article-title":"Origin of lignans in mammals and identification of a precursor in plants","volume":"298","author":"Axelson","year":"1982","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.yrtph.2004.09.001_bib4","first-page":"1","article-title":"Alpha2u-globulin-mediated male rat nephropathy and kidney cancer: relevance to human risk assessment","volume":"13","author":"Borghoff","year":"1993","journal-title":"CIIT Activ."},{"key":"10.1016\/j.yrtph.2004.09.001_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0015-6264(74)90236-3","article-title":"Two-year feeding and multigeneration studies in rats in five chemically modified starches","volume":"12","author":"DeGroot","year":"1974","journal-title":"Food Cosmet. Toxicol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib6","series-title":"Handbook of Toxicologic Pathology","first-page":"441","article-title":"Chapter 17. Risk assessment: the changing paradigm","author":"Durham","year":"1974"},{"key":"10.1016\/j.yrtph.2004.09.001_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/hfsg.1976.30.3.79","article-title":"Analysis of lignans in norway spruce by combined gas chromatography\u2014mass spectrometry","volume":"30","author":"Ekman","year":"1976","journal-title":"Holzforschung"},{"key":"10.1016\/j.yrtph.2004.09.001_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0015-6264(73)90064-3","article-title":"An evaluation of the criterion \u2018organ weight\u2019 under conditions of growth retardation","volume":"11","author":"Feron","year":"1973","journal-title":"Food Cosmet. Toxicol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib9","unstructured":"FDA Guidelines for Toxicological testing (1982). Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food. US Food and Drug Administration Bureau of Foods"},{"key":"10.1016\/j.yrtph.2004.09.001_bib10","series-title":"Histopathology of Preclinical Toxicity Studies","first-page":"534","article-title":"Chapter IX. Urinary tract","author":"Greaves","year":"1990"},{"key":"10.1016\/j.yrtph.2004.09.001_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(97)01339-1","article-title":"Case-control study of phyto-oestrogens and breast cancer","volume":"350","author":"Ingram","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2004.09.001_bib12","doi-asserted-by":"crossref","unstructured":"Kennel, P., Pallen, C., Barale-Thomas, E., Espuna, G., Bars, R., 2004. Tamoxifen: 28 day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects. Arch. Toxicol. 77, 487\u2013499","DOI":"10.1007\/s00204-003-0476-5"},{"key":"10.1016\/j.yrtph.2004.09.001_bib13","unstructured":"Lina, B.A.R., 2002. Sub-chronic (13-week) oral toxicity study with HM-3000 in rats. TNO report V4213"},{"key":"10.1016\/j.yrtph.2004.09.001_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/01926230152500004","article-title":"Proliferative lesions of ovarian granulosa cells and reversible hormonal changes induced in rats by a selective estrogen receptor modulator","volume":"29","author":"Long","year":"2001","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/rtph.1996.0055","article-title":"Low digestible carbohydrates (polyols and lactose): significance of adrenal medullary proliferative lesions in the rat","volume":"23","author":"Lynch","year":"1996","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1351\/pac199870091759","article-title":"Natural and anthropogenic environmental oestrogens: the scientific basis for risk assessment. Naturally occurring oestrogens in food","volume":"70","author":"Mazur","year":"1998","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.yrtph.2004.09.001_bib17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0899-9007(00)00333-6","article-title":"Overview of naturally occurring endocrine-active substances in the human diet in relation to human health","volume":"16","author":"Mazur","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.yrtph.2004.09.001_bib18","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/jn\/131.10.3036","article-title":"The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women","volume":"132","author":"McCann","year":"2002","journal-title":"J. Nutr."},{"key":"10.1016\/j.yrtph.2004.09.001_bib19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/jfca.2000.0932","article-title":"Assessment of data on lignan content of foods","volume":"13","author":"Meagher","year":"2000","journal-title":"J. Food Compos. Anal."},{"key":"10.1016\/j.yrtph.2004.09.001_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0300-483X(00)00465-0","article-title":"Initial induction and subsequent reduction of alpha(2u)-globulin in urine and serum of mature male rats after repeated intraperitoneal injections of (anti)estrogen","volume":"162","author":"Nagahori","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2004.09.001_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3835(97)00482-5","article-title":"Flaxseed and its mammalian lignan precursor cause a lengthening or cessation of estrous cycling in rats","volume":"125","author":"Orcheson","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yrtph.2004.09.001_bib22","unstructured":"OECD, 1998. Guideline for the Testing of Chemicals 408 Repeated Dose 90-day Oral Toxicity Studying Rodents. OECD, Paris"},{"key":"10.1016\/j.yrtph.2004.09.001_bib23","unstructured":"OECD, 1998. OECD Principles of Good Laboratory Practice ENV\/MC\/CHEM (98) 17. OECD, Paris"},{"key":"10.1016\/j.yrtph.2004.09.001_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0304-3835(00)00662-5","article-title":"Chemopreventive activity of crude hydroxymatairesinol (HMR) extract in APCmin mice","volume":"161","author":"Oikarinen","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yrtph.2004.09.001_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0041-008X(79)90066-8","article-title":"The effect of food restriction for 4 weeks on common toxicity parameters in male rats","volume":"47","author":"Oishi","year":"1979","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib26","unstructured":"Pe\u00f1alvo, J.L., Heinonen, M., Deyama, S., Nishibe, S., Adlercreutz, H., 2003. Characterization of sesame (sesamum indicum I.) seed lignans. (Karlsruhe 8th Nutrition Congress, Oct 12\u201314, 2003, Karlsruhe, Germany), abstract book p. 63"},{"key":"10.1016\/j.yrtph.2004.09.001_bib27","first-page":"339","article-title":"Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland","volume":"10","author":"Pietinen","year":"2001","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.yrtph.2004.09.001_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF01623898","article-title":"Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone","volume":"9","author":"Prasad","year":"2000","journal-title":"Int. Angiol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1207\/S15327914NC3602_10","article-title":"Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies)","volume":"36","author":"Saarinen","year":"2000","journal-title":"Nutr. Cancer Res."},{"key":"10.1016\/j.yrtph.2004.09.001_bib30","first-page":"869","article-title":"Enterolactone inhibits the growth of 7,12-dimethylbenz[a]anthracene-induced mammary carcinomas in rats","volume":"1","author":"Saarinen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.yrtph.2004.09.001_bib31","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1136\/gut.35.1_Suppl.S35","article-title":"Effects of short chain fatty acids on gut morphology and function","volume":"Suppl. 1","author":"Scheppach","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.yrtph.2004.09.001_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/np9701743","article-title":"Lignans interfering with 5-alpha.dihydrotestosterone binding to human sex hormone-binding globulin","volume":"61","author":"Sch\u00f6ttner","year":"1998","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.yrtph.2004.09.001_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0041-008X(89)90053-7","article-title":"The comparative pathobiology of alpha2-u-globulin nepropathy","volume":"97","author":"Swenberg","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib34","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/jn\/128.11.1861","article-title":"Flaxseed, and its lignan precursor, secoisolarcisiresinol- diglycoside, affect pregnancy outcome and reproductive performance in rats","volume":"128","author":"Tou","year":"1998","journal-title":"J. Nutr."},{"key":"10.1016\/j.yrtph.2004.09.001_bib35","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/carcin\/20.9.1831","article-title":"Exposure to flaxseed or its lignan component during different developmental stages influences mammary gland structures","volume":"20","author":"Tou","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yrtph.2004.09.001_bib36","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(99)05031-X","article-title":"Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study","volume":"354","author":"Vanharanta","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2004.09.001_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0021-9150(01)00603-7","article-title":"Association between low serum enterolactone and increased plasma F2 isoprostanes, a measure of lipid peroxidation","volume":"160","author":"Vanharanta","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yrtph.2004.09.001_bib38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.163.9.1099","article-title":"Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone. Kuopio ischaemic heart disease risk factor study","volume":"163","author":"Vanharanta","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.yrtph.2004.09.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2004.04.001","article-title":"Prenatal developmental toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats","volume":"40","author":"Wolterbeek","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0960-0760(94)90030-2","article-title":"Lignans and flavonoids inhibit aromatase activity in human preadipocytes","volume":"50","author":"Wang","year":"1994","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.yrtph.2004.09.001_bib41","first-page":"777:289","article-title":"Mammalian phytoestrogens: enterodiol and enterolactone","author":"Wang","year":"2002","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.yrtph.2004.09.001_bib42","unstructured":"WHO, 1987. Principles for the Safety Assessment of Food Additives and Contaminants in Food. World Health Organization (WHO), International Programme on Chemical Safety (IPCS); Geneva. Environmental Health Criteria, No. 70, 39\u201356"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230004001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230004001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T17:51:57Z","timestamp":1548957117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230004001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0273230004001308"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2004.09.001","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}